HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shizuko Kakinuma Selected Research

Proteins (Proteins, Gene)

8/2023Azithromycin induces read-through of the nonsense Apc allele and prevents intestinal tumorigenesis in C3B6F1 ApcMin/+ mice.
3/2017Analysis of genes involved in the PI3K/Akt pathway in radiation- and MNU-induced rat mammary carcinomas.
3/2015Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice.
11/2008Aberrant activation of interleukin-9 receptor and downstream Stat3/5 in primary T-cell lymphomas in vivo in susceptible B6 and resistant C3H mice.
4/2006Accelerated growth of intestinal tumours after radiation exposure in Mlh1-knockout mice: evaluation of the late effect of radiation on a mouse model of HNPCC.
2/2006Mammary tumorigenesis in ApcMin/+ mice is enhanced by X irradiation with a characteristic age dependence.
6/2005Cooperative induction of rat mammary cancer by radiation and 1-methyl-1-nitrosourea via the oncogenic pathways involving c-Myc activation and H-ras mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shizuko Kakinuma Research Topics

Disease

34Neoplasms (Cancer)
08/2023 - 10/2003
23Carcinogenesis
09/2023 - 11/2004
11Lymphoma (Lymphomas)
04/2024 - 10/2003
11Carcinoma (Carcinomatosis)
10/2022 - 04/2006
8T-Cell Lymphoma (Lymphoma, T Cell)
09/2015 - 03/2002
6Breast Neoplasms (Breast Cancer)
03/2023 - 05/2006
5Second Primary Neoplasms (Neoplasms, Second)
10/2019 - 01/2006
3Colonic Neoplasms (Colon Cancer)
03/2015 - 01/2006
2Adenoma (Adenomas)
04/2024 - 03/2013
2Adenocarcinoma
08/2023 - 03/2013
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
08/2023 - 03/2015
2Adenocarcinoma of Lung
11/2022 - 01/2017
2Lung Neoplasms (Lung Cancer)
11/2022 - 01/2017
2Body Weight (Weight, Body)
03/2022 - 03/2013
2Hepatocellular Carcinoma (Hepatoma)
06/2016 - 08/2012
2Colitis
03/2015 - 01/2006
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2008 - 01/2006
1Glioma (Gliomas)
06/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Radiation-Induced Neoplasms (Neoplasms, Radiation Induced)
01/2022
1Necrosis
01/2019
1Liver Neoplasms (Liver Cancer)
01/2017
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
03/2015
1Colitis-Associated Neoplasms
03/2015
1Radiation-Induced Leukemia (Leukemia, Radiation Induced)
11/2012
1Leukemia
08/2012
1Wounds and Injuries (Trauma)
06/2011
1Colorectal Neoplasms (Colorectal Cancer)
04/2011
1Chromosome Aberrations (Chromosome Abnormalities)
11/2007
1Neoplasm Metastasis (Metastasis)
09/2007
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2006

Drug/Important Bio-Agent (IBA)

13CarcinogensIBA
03/2023 - 06/2005
8DNA (Deoxyribonucleic Acid)IBA
03/2020 - 03/2002
7Proteins (Proteins, Gene)FDA Link
08/2023 - 06/2005
7CarbonIBA
11/2022 - 10/2003
6Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
10/2017 - 05/2005
5IonsIBA
11/2022 - 10/2003
4Drinking WaterIBA
08/2023 - 01/2006
4CytokinesIBA
01/2021 - 01/2004
3Messenger RNA (mRNA)IBA
08/2023 - 08/2010
3CateninsIBA
08/2023 - 03/2015
3Interleukin-9 Receptors (Interleukin 9 Receptor)IBA
08/2012 - 01/2004
2Azithromycin (Zithromax)FDA LinkGeneric
09/2023 - 08/2023
2Nonsense Codon (Nonsense Mutation)IBA
08/2023 - 04/2010
2Estrogen ReceptorsIBA
10/2022 - 01/2018
2LeptinIBA
03/2022 - 01/2021
2Hormones (Hormone)IBA
01/2021 - 01/2018
2Phenobarbital (Luminal)FDA Link
01/2021 - 03/2019
2Dextrans (Dextran)FDA Link
03/2015 - 01/2006
2Dihydrotachysterol (AT 10)IBA
03/2015 - 01/2006
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
03/2015 - 01/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2012 - 06/2004
2Transforming Growth Factors (Transforming Growth Factor)IBA
06/2011 - 04/2006
2beta CateninIBA
02/2006 - 01/2006
2Codon (Codons)IBA
06/2005 - 03/2002
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
04/2024
1Cyclin D1IBA
08/2023
1Anti-Bacterial Agents (Antibiotics)IBA
08/2023
1MacrolidesIBA
08/2023
1Antineoplastic Agents (Antineoplastics)IBA
08/2023
1arseniteIBA
06/2023
1A-Form DNA (A-DNA)IBA
10/2022
1Insulin (Novolin)FDA Link
03/2022
1Triglycerides (Triacylglycerol)IBA
03/2022
1CholesterolIBA
03/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Interleukin-2 (IL2)IBA
01/2021
1Granzymes (Granzyme)IBA
01/2021
1PlasticsIBA
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2018
1ProgesteroneFDA LinkGeneric
01/2018
1Estradiol (Delestrogen)FDA LinkGeneric
01/2018
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2018
1Polycomb Repressive Complex 2IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017
1MutL Protein Homolog 1IBA
03/2015
1AminesIBA
03/2013
1Apoprotein(a) (Apolipoprotein (a))IBA
03/2013
1diisopropanolnitrosamineIBA
03/2013
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2013
1Surface-Active Agents (Surfactants)IBA
03/2013
1ApoferritinsIBA
11/2012
1NucleolinIBA
08/2012
1Interleukin-9 (Interleukin 9)IBA
08/2012
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2011
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
04/2010
1Alkylating AgentsIBA
09/2009
1Untranslated RNA (Noncoding RNA)IBA
07/2008
1Quinacrine (Mepacrine)IBA
11/2007
1Estrogen Receptor alphaIBA
09/2007
1Surface Antigens (Surface Antigen)IBA
07/2006

Therapy/Procedure

10Radiotherapy
06/2023 - 01/2006
4Therapeutics
11/2022 - 03/2013
2Aftercare (After-Treatment)
01/2021 - 03/2013
2Heavy Ion Radiotherapy
01/2021 - 01/2015
1Intraperitoneal Injections
10/2022
1Nuclear Power Plants
01/2021
1Caloric Restriction
06/2016